Walpar Nutritions
WALPARNSE

Walpar Nutritions

₹37.250.25 (0.68%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
37.00
Today’s high
38.00
52 week low
36.00
52 week high
53.30
Open price
38.00
Previous close
37.00
Live volume
8,000
Lower circuit
35.15
Upper circuit
38.85

Fundamentals

Market Cap
₹35Cr
ROE
13.13%
P/E Ratio(TTM)
12.42
EPS(TTM)
2.98
P/B Ratio
2.10
Dividend Yield
0.00%
Industry P/E
33.75
Book Value
17.63
Debt to Equity
0.48
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2025
Revenue (Cr)
₹72.03
+14.81%
Profit (Cr)
₹2.80
+43.82%
06.252556.25100
2021
2022
2023
2024
2025
Revenue growthValue
3Y CAGR+39%
Profit growthValue
3Y CAGR+99%

About

Walpar Nutritions operates within a single business segment, focusing on the manufacturing and trading of pharmaceutical, nutraceutical, herbal, and Ayurvedic commodities. For the 2024-25 year, the company plans to expand its product line to meet the specific requirements of both the Indian and global markets. To support this expansion, the firm will increase its focus on dedicated research and development initiatives and aim for higher overall productivity. The company maintains a diverse portfolio of products and utilizes a wide network for sales, marketing, and distribution across various fill volumes. Management has adopted superior and advanced technology for producing its wide range of pharmaceutical, nutraceutical, Ayurvedic, and herbal products. Demonstrating its market performance, the company's total turnover for the financial year 2023-24 reached a significant ₹5144.38 Lakhs.;
CEO/MD
Kalpesh Pravinchandra Ladhawala
Founded in
2020
NSE symbol
WALPAR

Shareholding Pattern

Mar '24
Sep '24
Mar '25
Sep '25
Mar '26
Promoters
68.82%
Retail And Others
31.18%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹399.15
+20.95 (5.54%)
L
    H
    4,125.4286.2415.6
    ₹421.50
    +7.50 (1.81%)
    L
      H
      3,879.0743.285.32
      Aarti DrugsAARTIDRUGS
      ₹397.65
      -2.80 (0.70%)
      L
        H
        3,635.2817.962.48
        Orchid PharmaORCHPHARMA
        ₹682.05
        +20.50 (3.10%)
        L
          H
          3,363.18178.252.64
          Recent news is not available for this stock
          2025
          13
          Nov
          Result
          Release date
          2024

          14
          Aug
          Bonus
          Ex date
          1:1
          Ratio

          For every 1 shares you hold, you will receive 1 additional shares
          Bonus ratio1:1
          Ex date14 Aug ‘24
          Record date14 Aug ‘24
          Announcement date9 Aug ‘24

          9
          Aug
          Bonus
          Announced
          1:1
          Ratio

          For every 1 shares you hold, you will receive 1 additional shares
          Bonus ratio1:1
          Ex date14 Aug ‘24
          Record date14 Aug ‘24
          Announcement date9 Aug ‘24
          Events calendar
          View upcoming events in other stocks